On the search for the right definition of heart failure with preserved ejection fraction.

The definition of heart failure with preserved ejection fraction (HFpEF) has evolved from a clinically based "diagnosis of exclusion" to definitions focused on objective evidence of diastolic dysfunction and/or elevated left ventricular filling pressures. Despite advances in our understanding of HFpEF pathophysiology and the development of more sophisticated imaging modalities, the diagnosis of HFpEF remains challenging, especially in the chronic setting, given that symptoms are provoked by exertion and diagnostic evaluation is largely conducted at rest. Invasive hemodynamic study, and in particular - invasive exercise testing, is considered the reference method for HFpEF diagnosis. However, its use is limited as opposed to the high number of patients with suspected HFpEF. Thus, diagnostic criteria for HFpEF should be principally based on non-invasive measurements. Because no single non-invasive variable can adequately corroborate or refute the diagnosis, different combinations of clinical, echocardiographic, and/or biochemical parameters have been introduced. Recent years have brought an abundance of HFpEF definitions. Here, we present and compare four of them: 1) the 2016 European Society of Cardiology (ESC) criteria for HFpEF; 2) the 2016 echocardiographic algorithm for diagnosing diastolic dysfunction; 3) the 2018 evidence-based H₂FPEF score; and 4) the most recent, 2019 Heart Failure Association HFA-PEFF algorithm. These definitions vary in their approach to diagnosis, as well as sensitivity and specificity. Further studies to validate and compare the diagnostic accuracy of HFpEF definitions are warranted. Nevertheless, it seems that the best HFpEF definition would originate from a randomized clinical trial showing a favorable effect of an intervention on prognosis in HFpEF.

[1]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[2]  J. Daubert,et al.  Do Patients With Acute Heart Failure and Preserved Ejection Fraction Have Heart Failure at Follow-Up: Implications of the Framingham Criteria. , 2020, Journal of cardiac failure.

[3]  G. Filippatos,et al.  Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology ‐ Heart Failure Association EURObservational Research Programme Heart Failure Long‐Term Registry , 2020, ESC heart failure.

[4]  L. Ling,et al.  Heart failure with preserved ejection fraction diagnostic scores in an Asian population , 2020, European journal of heart failure.

[5]  G. Lewis,et al.  DIAGNOSING HFPEF: VALIDATION OF A NONINVASIVE DIAGNOSTIC APPROACH AGAINST INVASIVE HEMODYNAMICS , 2020 .

[6]  G. Kararigas,et al.  Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.

[7]  I. Komuro,et al.  Estrogen Receptor-α Non-Nuclear Signaling Confers Cardioprotection and Is Essential to cGMP-PDE5 Inhibition Efficacy , 2020, JACC. Basic to translational science.

[8]  J. Oh,et al.  The 2016 Diastolic Function Guideline: Is it Already Time to Revisit or Revise Them? , 2020, JACC. Cardiovascular imaging.

[9]  A. Klein,et al.  Imaging of Diastolic Dysfunction in Community-Based Epidemiological Studies and Randomized Controlled Trials of HFpEF. , 2020, JACC. Cardiovascular imaging.

[10]  Sanjiv J. Shah,et al.  Validation of the HFA‐PEFF score for the diagnosis of heart failure with preserved ejection fraction , 2019, European journal of heart failure.

[11]  K. Sakamoto,et al.  H2FPEF Score as a Prognostic Value in HFpEF patients. , 2019, American journal of hypertension.

[12]  M. Senni,et al.  Usefulness and clinical relevance of left ventricular global longitudinal systolic strain in patients with heart failure with preserved ejection fraction , 2019, Heart Failure Reviews.

[13]  Akshay S. Desai,et al.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. , 2019, The New England journal of medicine.

[14]  Erwan Donal,et al.  How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). , 2019, European heart journal.

[15]  W. Paulus,et al.  Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction? , 2019, Circulation.

[16]  G. Lewis,et al.  Differential Clinical Profiles, Exercise Responses and Outcomes Associated with Existing HFpEF Definitions. , 2019, Circulation.

[17]  Sanjiv J. Shah,et al.  Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study. , 2019, Mayo Clinic proceedings.

[18]  Thomas H. Marwick,et al.  Contribution of Cardiovascular Reserve to Prognostic Categories of Heart Failure With Preserved Ejection Fraction: A Classification Based on Machine Learning , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  J. Mariani,et al.  Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis. , 2019, JACC. Heart failure.

[20]  C. Yancy,et al.  Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[21]  Jiayin Zhang,et al.  Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance , 2019, European Radiology.

[22]  G. Filippatos,et al.  Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry , 2018, European heart journal.

[23]  H. Yasue,et al.  Sex Differences in Heart Failure With Preserved Ejection Fraction Reflected by B‐type Natriuretic Peptide Level , 2018, The American journal of the medical sciences.

[24]  W. Shimizu,et al.  Heart failure with preserved ejection fraction in Asia , 2018, European journal of heart failure.

[25]  M. Obokata,et al.  The strengths and limitations of E/e' in heart failure with preserved ejection fraction , 2018, European journal of heart failure.

[26]  S. Solomon,et al.  Heart failure with preserved ejection fraction: from mechanisms to therapies , 2018, European heart journal.

[27]  R. Cocchia,et al.  Reference Ranges and Physiologic Variations of Left E/e' Ratio in Healthy Adults: Clinical and Echocardiographic Correlates , 2018, Journal of cardiovascular echography.

[28]  W. Kosmala Diagnosing HFpEF: On Track at Last? , 2018, JACC. Cardiovascular imaging.

[29]  S. Hansen,et al.  The validity of the diagnosis of heart failure (I50.0-I50.9) in the Danish National Patient Register. , 2018, Danish medical journal.

[30]  J. McMurray,et al.  Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry , 2018, PLoS medicine.

[31]  O. Smiseth Evaluation of left ventricular diastolic function: state of the art after 35 years with Doppler assessment , 2017, Journal of Echocardiography.

[32]  M. Humbert,et al.  An official European Respiratory Society statement: pulmonary haemodynamics during exercise , 2017, European Respiratory Journal.

[33]  E. Schwammenthal,et al.  Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study , 2017, European heart journal cardiovascular Imaging.

[34]  B. Pieske,et al.  Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis , 2017, Open Heart.

[35]  L. Lund,et al.  Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. , 2017, JACC. Heart failure.

[36]  V. Melenovský,et al.  Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction , 2017, Circulation.

[37]  Shannon M. Dunlay,et al.  Epidemiology of heart failure with preserved ejection fraction , 2017, Nature Reviews Cardiology.

[38]  E. Remme,et al.  Estimating Left Ventricular Filling Pressure by Echocardiography. , 2017, Journal of the American College of Cardiology.

[39]  M. Domingo,et al.  Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study , 2017, The European journal of general practice.

[40]  J. Felius,et al.  Probability of Accurate Heart Failure Diagnosis and the Implications for Hospital Readmissions. , 2017, The American journal of cardiology.

[41]  H. Gupta,et al.  What Is the Evidence That the Tissue Doppler Index E/e′ Reflects Left Ventricular Filling Pressure Changes After Exercise or Pharmacological Intervention for Evaluating Diastolic Function? A Systematic Review , 2017, Journal of the American Heart Association.

[42]  V. Melenovský,et al.  Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study , 2016, Circulation.

[43]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[44]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[45]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[46]  M. Peller,et al.  Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry). , 2016, The American journal of cardiology.

[47]  R. D. de Boer,et al.  Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides , 2016, Netherlands Heart Journal.

[48]  W. Paulus,et al.  Understanding heart failure with preserved ejection fraction: where are we today? , 2016, Netherlands Heart Journal.

[49]  T. Marwick,et al.  Contributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction. , 2016, Journal of the American College of Cardiology.

[50]  T. Denney,et al.  Diagnostic Accuracy of Tissue Doppler Index E/è for Evaluating Left Ventricular Filling Pressure and Diastolic Dysfunction/Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta‐Analysis , 2016, Journal of the American Heart Association.

[51]  P. Ennezat,et al.  Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction , 2016, Journal of the American Heart Association.

[52]  K. Sakata,et al.  Comparison of the reliability of E/E′ to estimate pulmonary capillary wedge pressure in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction , 2015, The International Journal of Cardiovascular Imaging.

[53]  Ruoxiang Jiang,et al.  A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. , 2015, JAMA internal medicine.

[54]  K. Anstrom,et al.  Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial , 2017, European journal of heart failure.

[55]  P. Śliwiński,et al.  Factors associated with diastolic dysfunction in patients with resistant hypertension: resist-POL study. , 2015, American journal of hypertension.

[56]  Michael A. Burke,et al.  Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction , 2015, Circulation.

[57]  Sanjiv J Shah,et al.  Spironolactone for heart failure with preserved ejection fraction. , 2014, The New England journal of medicine.

[58]  Emanuele Romeo,et al.  Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension. , 2013, International journal of cardiology.

[59]  Manesh R. Patel,et al.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. , 2013, JAMA.

[60]  Michael A. Burke,et al.  Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. , 2012, The American journal of cardiology.

[61]  R. Vasan,et al.  Epidemiology and clinical course of heart failure with preserved ejection fraction , 2011, European journal of heart failure.

[62]  R. Nishimura,et al.  Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction , 2010, Circulation. Heart failure.

[63]  Nancy M Albert,et al.  HFSA 2010 Comprehensive Heart Failure Practice Guideline. , 2010, Journal of cardiac failure.

[64]  W. Paulus,et al.  Treatment of heart failure with normal ejection fraction: an inconvenient truth! , 2010, Journal of the American College of Cardiology.

[65]  Thor Edvardsen,et al.  Determinants of Left Ventricular Early-Diastolic Lengthening Velocity: Independent Contributions From Left Ventricular Relaxation, Restoring Forces, and Lengthening Load , 2009, Circulation.

[66]  M. Corretti,et al.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. , 2009, American journal of respiratory and critical care medicine.

[67]  R. Rodeheffer,et al.  Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population , 2009, Circulation.

[68]  W Frank Peacock,et al.  State of the art: Using natriuretic peptide levels in clinical practice , 2008, European journal of heart failure.

[69]  F. Flachskampf,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[70]  B. Rutkowski,et al.  Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end-stage renal disease. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[71]  Bruce D. Johnson,et al.  Impact of preload and afterload on global and regional right ventricular function and pressure: a quantitative echocardiography study. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[72]  M. Cowie,et al.  The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study , 2005, European journal of heart failure.

[73]  E. Shapiro,et al.  Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit , 2005 .

[74]  R. Pecoits-Filho,et al.  Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic Doppler parameters in patients with end-stage renal disease. , 2004, The American journal of cardiology.

[75]  P. Mottram,et al.  Effect of preload reduction by haemodialysis on new indices of diastolic function. , 2003, Clinical science.

[76]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[77]  N. Freemantle,et al.  Perindopril for elderly people with chronic heart failure: the PEP‐CHF study , 1999, European heart journal.

[78]  J. Ge Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy. , 2020, Cardiology journal.

[79]  A. Shah,et al.  Invasive Validation of the Echocardiographic Assessment of Left Ventricular Filling Pressures Using the 2016 Diastolic Guidelines: Head‐to‐Head Comparison with the 2009 Guidelines , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[80]  J. Kasprzak,et al.  The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction. , 2017, Cardiology journal.

[81]  L. Santos-Martínez,et al.  Interobserver agreement on the echocardiographic parameters that estimate right ventricular systolic function in the early postoperative period of cardiac surgery. , 2016, Medicina intensiva.

[82]  Simon Gibbs,et al.  [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.

[83]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[84]  E. Villacorta,et al.  Inter- and intra-observer variability in the echocardiographic evaluation of right ventricular function. , 2010, Revista espanola de cardiologia.

[85]  R. McKelvie,et al.  The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart FailureWith Preserved Ejection Fraction , 2022 .